Skip to content
★ Sign in to follow
YD

Yamo Deniz

Executive
Flexion Therapeutics Inc
Total declarations
4
Company
1
▲ Purchases (4 ops.)
€110k
▼ Sales (0 ops.)
—

Latest filing published 15 Sept 2017 for Flexion Therapeutics Inc, €29k.

Filing timeline

BuySale
Yamo Deniz

Insider track record

Disclosed buys
4
Disclosed sells
0
Signal history

Closed purchases

Market purchases
4

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Yamo Deniz: trading record in brief

This profile gathers the share dealings of Yamo Deniz in Flexion Therapeutics Inc. Over a trading history stretching from 31 August 2017 to 5 September 2017, the count stands at 4 filings.

Purchases make up the whole of the open-market record (4 purchases, €110k). Unlike grants, an open-market purchase is paid for by the insider, at the market price.

A typical purchase (the median) is worth €25k. No cluster: in 4 purchases, no other insider of the company bought within 30 days.

The latest filing, published on 15 September 2017, reports an open-market purchase of €29k in Flexion Therapeutics Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 14 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Yamo Deniz

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations4 total
  • ▲
    Chief Medical OfficerExecutivesFlexion Therapeutics Inc
    34,925 USD14SEC
    1,375 shares@ US$25.4026.5% of flowCommon StockSEC:0001209191-17-053024:0
    Canonical exit: 29 Nov 2017 (T+90)
  • ▲
    Chief Medical OfficerExecutivesFlexion Therapeutics Inc
    24,550 USD15SEC
    1,000 shares@ US$24.5518.7% of flowCommon StockSEC:0001209191-17-053024:1
    Canonical exit: 30 Nov 2017 (T+90)
  • ▲
    Chief Medical OfficerExecutivesFlexion Therapeutics Inc
    47,900 USD17SEC
    2,000 shares@ US$23.9536.4% of flowCommon StockSEC:0001209191-17-053024:2
    Canonical exit: 30 Nov 2017 (T+90)
  • ▲
    Chief Medical OfficerExecutivesFlexion Therapeutics Inc
    24,200 USD19SEC
    1,000 shares@ US$24.2018.4% of flowCommon StockSEC:0001209191-17-053024:3
    Canonical exit: 4 Dec 2017 (T+90)

4 of 4 declarations